Inmune Bio, Inc. (INMB) › Net IncomeInmune Bio, Inc. (INMB) — Net IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$831.5K2018-12-31: -$12.44M2019-12-31: -$7.68M2020-12-31: -$12.10M2021-12-31: -$30.34M2022-12-31: -$27.30M2023-12-31: -$30.01M2024-12-31: -$42.08M2025-12-31: -$45.93M-$45.93M2017-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$45.93M—2026-03-30From 2025-01-012024-12-31-$42.08M—2026-03-30From 2024-01-012023-12-31-$30.01M—2025-03-27From 2023-01-012022-12-31-$27.30M—2024-03-28From 2022-01-012021-12-31-$30.34M—2023-03-02From 2021-01-012020-12-31-$12.10M—2022-03-03From 2020-01-012019-12-31-$7.68M—2021-03-04From 2019-01-012018-12-31-$12.44M—2020-03-11From 2018-01-012017-12-31-$831.5K—2019-03-29From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)